NH Investment & Securities Downgrades Amorepacific Target Price, Maintains 'Buy' Rating

Reporter Kim SangJin / approved : 2024-09-09 03:12:19
  • -
  • +
  • 인쇄

(Photo= Yonhap news)

 

[Alpha Biz= Reporter Kim Sangjin] NH Investment & Securities has maintained a 'Buy' rating on Amorepacific but revised its target price from 200,000 won to 180,000 won.

The firm stated, "Even with a conservative assumption that the loss from China will remain at 115 billion won next year, we believe Amorepacific's valuation floor is set at 7.6 trillion won. This adjustment presents a mid-to-long-term buying opportunity."

NH Investment & Securities forecasts that Amorepacific's third-quarter consolidated revenue will reach 970.8 billion won (+9% YoY), with an operating profit of 38 billion won (+120%). However, this operating profit is expected to fall 28% short of expectations.

The company noted, "Domestic cosmetics sales are projected to be 430.2 billion won (-3%) with an operating profit of 21.5 billion won (-1%) due to a 27% decline in duty-free sales, which will reduce domestic profitability." It also expects sales of consumer goods to be 90.9 billion won (-7%) with an operating loss of 2.5 billion won, citing intensified competition in mid-to-low-priced product categories in some channels.

On the international front, NH Investment & Securities anticipates overseas revenue of 434.8 billion won (+37%) and operating profit of 22.3 billion won (turning positive). Regional forecasts include a 43% decline in China, a 20% increase in North America, and a 25% increase in EMEA (Europe, the Middle East, and Africa). The firm expects an operating loss of 51 billion won due to structural changes in the China distribution business, inventory write-offs, and workforce restructuring.

 

 

Alphabiz Reporter Kim SangJin(letyou@alphabiz.co.kr)

어플

주요기사

Bomb Threats Target Major Korean Companies Including Samsung Electronics2025.12.19
FSS Raises Consumer Alert to “Warning” Over Secondary Scams Linked to Coupang Data Breach2025.12.19
Final U.S. Defense Authorization Bill Omits Provisions Supporting South Korea-Japan Shipbuilding Cooperation2025.12.19
Controversy Surrounds KT’s Former Outside Director Cho Seung-ah Amid Dual Directorship Issue2025.12.19
Samsung Securities Lowers LG Energy Solution Target Price to KRW 480,000 Amid Contract Cancellations2025.12.19
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사